Neuroprotection achieved with a novel proteasome inhibitor which blocks NF-κB activation

NeuroReport

Volumn 11, Issue 2, 2000, Pages 427-430

  Buchan, A M ^a   Li, H ^a   Blackburn, B ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b CV THERAPEUTICS INC   (United States)

Author keywords

Apoptosis; Ischemia; NF B; Proteasome; Stroke

Indexed keywords

5 METHOXY 1 INDANONE 3 ACETYL LEUCYL DEXTRO LEUCYL 1 INDANYLAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION; DRUG EFFICACY; DRUG MECHANISM; MALE; NEUROPROTECTION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RAT;

EID: 0033979693     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200002070-00041     Document Type: Article

References (24)

1. 1. Lipton SA. Nature Med 3, 20-22 (1997).
2. 2. Baichwal VR and Beauerle PA. Curr Biol 7, R94-R96 (1997).
3. 3. Clemens JA, Stephenson DT, Smalstig EB et al. Stroke 28, 1073-1081 (1997).
4. 4. Clemens JA, Stephenson DT, Dixon EP et al. Mol Brain Res 48, 187-196 (1997).
5. 5. Schneider A, Martin-Villalba A, Weih F et al. Nature Med 5, 554-559 (1999).
6. 6. O'Neill LAJ and Kalschmidt C. Trends Neurosci: 20, 252-258 (1997).
7. 7. Salminen A, Liu PK and Hse CY. Biochem Biophys Res Commun 212, 939-944 (1995).
8. 8. Grilli M, Pizzi M, Memo M et al. Science 274, 1383-1385 (1996).
9. 9. Lum RT, Kerwar SS, Meyer SM et al. Biochem Pharmacol 55, 1391-1397 (1998).
10. 10. Buchan AM, Xue D and Slivka A. Stroke 23, 273-279 (1992).
11. 11. Kaltschmidt C, Kaltschmidt B and Baeuerle PA. Proc Natl Acad Sci USA 92, 9618-9622 (1995).
12. 12. Mattson MP, Goodman Y, Luo H et al. J Neurosci Res 49, 681-697 (1997).
13. 13. Clemens JA, Stephenson DT, Tinggui Y et al. Stroke 29, 677-682 (1998).
14. 14. Qin Z-H, Wang Y, Nakai M et al. Mol Pharmacol 53, 33-42 (1998).
15. 15. Rong Y and Baudry M. J Neurochem 67, 662-668 (1996).
16. 16. Yang K, Mu XS and Hayes RL. Neurosci Lett 197, 101-104 (1995).
17. 17. Kaltschmidt B, Uherek M, Volk B et al. Proc Natl Acad Sci USA 94, 2642-2647 (1997).
18. 18. Hunot S, Brugg B, Ricard D et al. Proc Natl Acad Sci USA 94, 7531-7536 (1997).
19. 19. Meyer S, Kohler NG and Joly A. FEBS Lett 413, 354-358 (1997).
20. 20. Carroll JE, Howard EF, Hess DC et al. Mol Brain Res 56, 186-191 (1998).
21. 21. Matsumoto S, Friberg H, Ferrand-Drake M et al. J Cerebr Blood Flow Metab 19, 736-741 (1999).
22. 22. Goldberg AL, Akopian TN, Kisselev AF et al. Biol Chem 378, 131-140 (1997).
23. 23. Kawazoe Y, Nakai A, Tanabe M et al. Eur J Biochem 255, 356-362 (1998).
24. 24. Kim D, Kim S-H and Li CC. Biochem Biophys Res Commun 254, 264-268 (1999).